Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
17135278
TITLE
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.
ABSTRACT
Nicotine dependence is one of the world's leading causes of preventable death. To discover genetic variants that influence risk for nicotine dependence, we targeted over 300 candidate genes and analyzed 3713 single nucleotide polymorphisms (SNPs) in 1050 cases and 879 controls. The Fagerström test for nicotine dependence (FTND) was used to assess dependence, in which cases were required to have an FTND of 4 or more. The control criterion was strict: control subjects must have smoked at least 100 cigarettes in their lifetimes and had an FTND of 0 during the heaviest period of smoking. After correcting for multiple testing by controlling the false discovery rate, several cholinergic nicotinic receptor genes dominated the top signals. The strongest association was from an SNP representing CHRNB3, the beta3 nicotinic receptor subunit gene (P = 9.4 x 10(-5)). Biologically, the most compelling evidence for a risk variant came from a non-synonymous SNP in the alpha5 nicotinic receptor subunit gene CHRNA5 (P = 6.4 x 10(-4)). This SNP exhibited evidence of a recessive mode of inheritance, resulting in individuals having a 2-fold increase in risk of developing nicotine dependence once exposed to cigarette smoking. Other genes among the top signals were KCNJ6 and GABRA4. This study represents one of the most powerful and extensive studies of nicotine dependence to date and has found novel risk loci that require confirmation by replication studies.
DATE PUBLISHED
2007 Jan 1
HISTORY
PUBSTATUS PUBSTATUSDATE
aheadofprint 2006/11/29
pubmed 2006/12/01 09:00
medline 2007/04/04 09:00
entrez 2006/12/01 09:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Saccone SF Saccone Scott F SF Department of Psychiatry, Box 8134, Washington University School of Medicine, 660 South Euclid Avenue, St Louis, MO 63110, USA. saccones@msnotes.wustl.edu
Hinrichs AL Hinrichs Anthony L AL
Saccone NL Saccone Nancy L NL
Chase GA Chase Gary A GA
Konvicka K Konvicka Karel K
Madden PA Madden Pamela A F PA
Breslau N Breslau Naomi N
Johnson EO Johnson Eric O EO
Hatsukami D Hatsukami Dorothy D
Pomerleau O Pomerleau Ovide O
Swan GE Swan Gary E GE
Goate AM Goate Alison M AM
Rutter J Rutter Joni J
Bertelsen S Bertelsen Sarah S
Fox L Fox Louis L
Fugman D Fugman Douglas D
Martin NG Martin Nicholas G NG
Montgomery GW Montgomery Grant W GW
Wang JC Wang Jen C JC
Ballinger DG Ballinger Dennis G DG
Rice JP Rice John P JP
Bierut LJ Bierut Laura Jean LJ
INVESTIGATORS
JOURNAL
VOLUME: 16
ISSUE: 1
TITLE: Human molecular genetics
ISOABBREVIATION: Hum. Mol. Genet.
YEAR: 2007
MONTH: Jan
DAY: 1
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Print
ISSN: 0964-6906
ISSNTYPE: Print
MEDLINE JOURNAL
MEDLINETA: Hum Mol Genet
COUNTRY: England
ISSNLINKING: 0964-6906
NLMUNIQUEID: 9208958
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, N.I.H., Extramural
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Pharmacogenetics. 2001 Jun;11(4):331-9 11434511
Cites Health Psychol. 1999 Jan;18(1):14-20 9925041
Cites Genome Res. 2002 Oct;12(10):1599-610 12368253
Cites Alcohol Clin Exp Res. 2003 May;27(5):733-42 12766617
Cites Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5 12883005
Cites Ann N Y Acad Sci. 2003 Sep;998:41-52 14592862
Cites Am J Hum Genet. 2004 Jan;74(1):106-20 14681826
Cites Nat Rev Neurosci. 2004 Jan;5(1):55-65 14708004
Cites Mol Pharmacol. 2004 Jun;65(6):1526-35 15155845
Cites Am J Hum Genet. 2004 Jul;75(1):112-21 15154117
Cites Psychol Med. 2004 Jul;34(5):865-79 15500307
Cites Stat Med. 1990 Jul;9(7):811-8 2218183
Cites Br J Addict. 1991 Sep;86(9):1119-27 1932883
Cites Brain Res. 1994 Aug 8;653(1-2):278-84 7982062
Cites Pharmacogenetics. 1996 Feb;6(1):73-9 8845863
Cites Pharmacogenetics. 1996 Jun;6(3):261-3 8807667
Cites Protein Eng. 1997 Jun;10(6):673-6 9278280
Cites Pharmacogenetics. 1997 Oct;7(5):411-4 9352579
Cites J Natl Cancer Inst. 1998 Mar 4;90(5):358-63 9498485
Cites Bioinformatics. 2005 Jan 15;21(2):263-5 15297300
Cites Science. 2005 Feb 18;307(5712):1072-9 15718463
Cites Behav Neurosci. 2005 Feb;119(1):26-37 15727510
Cites Am J Hum Genet. 2005 May;76(5):859-64 15759211
Cites Hum Mol Genet. 2005 May 1;14(9):1211-9 15790597
Cites MMWR Morb Mortal Wkly Rep. 2005 Jul 1;54(25):625-8 15988406
Cites Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5;139B(1):73-80 16152573
Cites Am J Hum Genet. 2006 Feb;78(2):243-52 16400608
Cites Mol Psychiatry. 2006 Mar;11(3):312-22, 223 16314871
Cites Lancet. 2006 Mar 4;367(9512):749-53 16517275
Cites Curr Psychiatry Rep. 2006 Apr;8(2):158-64 16539894
Cites Genet Epidemiol. 2006 Sep;30(6):459-70 16685721
Cites Hum Mol Genet. 2007 Jan 1;16(1):24-35 17158188
Cites Hum Mol Genet. 2005 Jun 15;14(12):1691-8 15879433
Cites Nat Neurosci. 1999 Dec;2(12):1084-90 10570485
Cites Mol Psychiatry. 2000 Mar;5(2):181-8 10822346
Cites Mol Psychiatry. 2000 Mar;5(2):189-92 10822347
Cites Genetics. 2000 Jun;155(2):945-59 10835412
Cites Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):453-8 9641486
Cites Nature. 1998 Jun 25;393(6687):750 9655391
Cites Mol Pharmacol. 2002 Aug;62(2):334-42 12130686
GRANTS
GRANTID AGENCY COUNTRY
CA89392 NCI NIH HHS United States
DA015129 NIDA NIH HHS United States
DA12854 NIDA NIH HHS United States
N01DA-0-7079 NIDA NIH HHS United States
P01 CA089392 NCI NIH HHS United States
P01 CA089392-05 NCI NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Adult
Aged
Aged, 80 and over
Case-Control Studies
Chromosomes, Human, Pair 8
Cluster Analysis
Female
Genetic Markers genetics
Genetic Variation genetics
Genotype genetics
Humans genetics
Male genetics
Middle Aged genetics
Polymorphism, Single Nucleotide genetics
Receptors, Nicotinic genetics
Tobacco Use Disorder genetics
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
0 Genetic Markers
0 Receptors, Nicotinic
OTHER ID's
OTHERID SOURCE
NIHMS32504 NLM
PMC2270437 NLM